6 years ago

ClinSpec Diagnostics Secures £1.2 Million for Cancer Detection Test

  • ClinSpec Diagnostics, a University of Glasgow spin-out developing a rapid blood test for brain cancer, secured £1.2 million in funding

  • Backers include Mercia Fund Managers, the Scottish Investment Bank’s Co-Investment Fund and EOS Technology Partners

  • The funding will be used to create seven jobs, further develop the brain cancer test, and start work on a new test for prostate and pancreatic cancer

  • ClinSpec Diagnostics’ technology, which uses infra-red light and machine learning, is based on research by Dr Matthew J

  • Baker at the University of Strathclyde and has applications beyond medicine.

      • ProblemHealthcare

      "Detecting brain cancer and other forms of cancer at an early stage is challenging, often leading to delayed treatment and reduced survival rates."

      Solution

      "ClinSpec Diagnostics has developed a blood test that can detect brain cancer within ten minutes, using infra-red light and machine learning, potentially improving survival rates through earlier detection."

      Covered on